Clinical Trials · NCT07221591
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Phase
- Phase 1
- Recruitment status
- Active Not Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 100
- Start date
- Nov 2025
- Locations
- 2 sites, Germany
- Primary endpoint
- Area under the concentration-time curve of the analyte in plasma at steady state over a uniform dosing interval τ (AUCτ,ss)